Biofarm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 14, 2021 at 11:00 am
Share
Biofarm S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was RON 62.366 million compared to RON 64.041 million a year ago. Operating income was RON 25.850 million compared to RON 23.366 million a year ago. Net income was RON 22.469 million compared to RON 18.588 million a year ago.
Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Companyâs product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.